One of the fund categories that is attracting a lot of attention from institutions and HNIs is arbitrage funds. Any arbitrage funds typically buys in equity and sells in stock futures. Here are the ...

The molecule, developed by its biotech division Sathgen Therapeutics, is currently undergoing Phase 1a clinical trials.

The company credited its performance to festive buying, particularly during Akshaya Tritiya, and steady wedding season sales.

The company has fixed the price band at ₹387 to ₹407 per share, allowing bids in multiples of 36 equity shares.

With the upgrade system, Southern Railway could meet its 3,000 MT loading target, announced the company in its filing with the bourses.

The latest data release from RBI indicates that for the first time in 2025 forex reserves crossed USD 700 bn. Despite a fall ...

As per CCI’s order dated May 26, 2025, India Cements is directed to present financial statements for FY15-FY19.

IndusInd Bank Limited posted a 3.9% decline in net advances to ₹3,34,477 Crore for the quarter ended June 30, 2025. In the ...